Author
Listed:
- Sadeem Ahmad
(Boston Children’s Hospital
Harvard Medical School)
- Tao Zou
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT)
- Jihee Hwang
(Harvard Medical School
Harvard Medical School)
- Linlin Zhao
(Harvard Medical School
Tongji University)
- Xi Wang
(Boston Children’s Hospital
Harvard Medical School)
- Anton Davydenko
(Boston Children’s Hospital
Harvard Medical School)
- Ilana Buchumenski
(Bar-Ilan University)
- Patrick Zhuang
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT)
- Alyssa R. Fishbein
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT)
- Diego Capcha-Rodriguez
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT)
- Aaron Orgel
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT)
- Erez Y. Levanon
(Bar-Ilan University)
- Sua Myong
(Harvard Medical School
Harvard Medical School)
- James Chou
(Harvard Medical School
Chinese Academy of Sciences)
- Matthew Meyerson
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT
Harvard Medical School)
- Sun Hur
(Boston Children’s Hospital
Harvard Medical School)
Abstract
The innate immune sensor PKR for double-stranded RNA (dsRNA) is critical for antiviral defense, but its aberrant activation by cellular dsRNA is linked to various diseases. The dsRNA-binding protein PACT plays a critical yet controversial role in this pathway. We show that PACT directly suppresses PKR activation by endogenous dsRNA ligands, such as inverted-repeat Alu RNAs, which robustly activate PKR in the absence of PACT. Instead of competing for dsRNA binding, PACT prevents PKR from scanning along dsRNA—a necessary step for PKR molecules to encounter and phosphorylate each other for activation. While PKR favors longer dsRNA for increased co-occupancy and scanning-mediated activation, longer dsRNA is also more susceptible to PACT-mediated regulation due to increased PACT-PKR co-occupancy. Unlike viral inhibitors that constitutively suppress PKR, this RNA-dependent mechanism allows PACT to fine-tune PKR activation based on dsRNA length and quantity, ensuring self-tolerance without sequestering most cellular dsRNA.
Suggested Citation
Sadeem Ahmad & Tao Zou & Jihee Hwang & Linlin Zhao & Xi Wang & Anton Davydenko & Ilana Buchumenski & Patrick Zhuang & Alyssa R. Fishbein & Diego Capcha-Rodriguez & Aaron Orgel & Erez Y. Levanon & Sua , 2025.
"PACT prevents aberrant activation of PKR by endogenous dsRNA without sequestration,"
Nature Communications, Nature, vol. 16(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58433-x
DOI: 10.1038/s41467-025-58433-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58433-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.